REYKJAVIK, Iceland, July 31, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the completion of a private placement, …
TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines …
With Expanded Reach in 30+ Countries and Partnerships with Over 2000 Hospitals, CloudHospital is Bringing Healthcare to the World Stage. SEOUL, SOUTH KOREA, July 7, 2023 /EINPresswire.com/ -- CloudHospital, a trailblazer in cross-border healthcare …
LONDON und BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners („Aztiq“), eine auf den Biowissenschaftssektor spezialisierte Private-Equity-Gesellschaft, und Innobic (Asia) Company Limited („Innobic“), die Biowissenschaftssparte des …
LONDRES y BANGKOK, Tailandia, July 03, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”), una empresa de capital privado centrada en el sector de las ciencias biológicas, e Innobic (Asia) Company Limited (“Innobic”), la división de ciencias de la …
LONDRES et BANGKOK, Thaïlande, 03 juill. 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (« Aztiq »), une société de capital-investissement axée sur le secteur des sciences de la vie, et Innobic (Asia) Company Limited (« Innobic »), la branche sciences de …
LONDON dan BANGKOK, Thailand, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”), sebuah perusahaan ekuitas swasta yang berfokus pada sektor ilmu hayati, dan Innobic (Asia) Company Limited ("Innobic"), anak perusahaan ilmu hayati …
ロンドンおよびタイ・バンコク発, July 04, 2023 (GLOBE NEWSWIRE) -- ライフサイエンスセクターに重点を置く非公開会社のアズティック・ファーマ・パートナーズ (Aztiq Pharma Partners、「アズティック」) と、タイの石油・ガス複合企業PTTパブリックカンパニー (PTT Public Company Limited 、「PTT」) のライフサイエンス部門であるイノビック・アジア (Innobic (Asia) Company Limited、「イノビック」) …
런던/태국 방콕, July 04, 2023 (GLOBE NEWSWIRE) -- 생명과학 분야에 중점을 둔 사모펀드 운용사인 Aztiq Pharma Partners는 오늘 태국 석유 가스 대기업 PTT Public Company Limited의 생명과학 부문 자회사인 Innobic (Asia) Company Limited와 공동으로 다국적 제약사인 Lotus Pharmaceuticals (1795:TT)의 주식 25,095,850주를 주당 NT$ …
LONDON dan BANGKOK, Thailand, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”), sebuah syarikat ekuiti swasta yang memfokus kepada sektor sains hayat, dan Innobic (Asia) Company Limited (“Innobic”), cabang sains hayat konglomerat minyak …
LONDRES e BANGKOK, Tailândia, July 03, 2023 (GLOBE NEWSWIRE) -- A Aztiq Pharma Partners ("Aztiq"), uma empresa de private equity focada no setor de ciências da vida, e a Innobic (Asia) Company Limited ("Innobic"), o braço de ciências da …
ลอนดอนและกรุงเทพมหานคร ประเทศไทย, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”) บริษัทเอกชนซึ่งมุ่งเน้นไปที่ภาควิทยาศาสตร์เพื่อชีวิตและบริษัท Innobic (Asia) Company Limited (“Innobic”) ซ …
伦敦和泰国曼谷, July 04, 2023 (GLOBE NEWSWIRE) -- 专注于生命科学领域的私募公司Aztiq Pharma Partners（“Aztiq”）及泰国石油天然气集团PTT Public Company Limited（“PTT”）的生命科学事业部Innobic (Asia) Company Limited（“Innobic”）（合称“股东”）今日宣布，以每股新台币297元的价格出售25,095,850股跨国制药公司Lotus Pharmaceuticals（1795：TT；“ …
倫敦和泰國曼谷, July 04, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners（「Aztiq」)是一家專注於生命科學行業的私募股權公司，其與泰國石油和天然氣企業集團PTT Public Company Limited（「PTT」）的生命科學業務分支Innobic (Asia) Company Limited（「Innobic」）（統稱「股東」）今日宣佈出售跨國製藥公司Lotus Pharmaceuticals（1795:TT；「Lotus」、「公司」）25, …
LONDON and BANGKOK, Thailand, July 03, 2023 (GLOBE NEWSWIRE) -- Aztiq Pharma Partners (“Aztiq”), a private equity company focused on the life sciences sector, and Innobic (Asia) Company Limited (“Innobic”), the life science arm of Thai oil and gas …
REYKJAVIK, Iceland, June 28, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the US Food and Drug Administration …
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech ( …
HEMPE sponsor 2023 World Strength Games and Adaptive Strength World Championships, promoting natural natural pain relief alternatives and supporting athletes. WIMBORNE, DORSET, UNITED KINGDOM, May 31, 2023 /EINPresswire.com/ -- HEMPE Announced as Master …
REYKJAVIK, Iceland, May 31, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies …
Advanz Pharma secures exclusive rights from Alvotech to commercialize five proposed biosimilars in Europe The agreement includes proposed biosimilars to Simponi® (golimumab), Entyvio® (vedolizumab) and three additional early-stage undisclosed biosimilar …
06 days 11:38:01
